RNAi疗法Lumasiran-话题@MedSci

#RNAi疗法Lumasiran#

5篇内容 | 710人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1536872, encodeId=44a715368e287, content=<a href='/topic/show?id=7cad1554076' target=_blank style='color:#2F92EE;'>#RNAi疗法Lumasiran#</a>, objectTitle=RNAi疗法lumasiran获得欧盟批准治疗1型原发性高草酸尿症, objectType=article, longId=203573, objectId=5fc22035e3b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fc22035e3b4, replyNumber=0, likeNumber=33, createdTime=2020-11-22, rootId=0, userName=fzwish20004, userId=fe1712732896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fc22035e3b4, moduleTitle=RNAi疗法lumasiran获得欧盟批准治疗1型原发性高草酸尿症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fc22035e3b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536871, encodeId=958915368e124, content=<a href='/topic/show?id=7cad1554076' target=_blank style='color:#2F92EE;'>#RNAi疗法Lumasiran#</a>, objectTitle=全球第三款RNAi疗法lumasiran即将获批，治疗罕见肝病——1型原发性高草酸尿症, objectType=article, longId=202546, objectId=dae520254669, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dae520254669, replyNumber=0, likeNumber=33, createdTime=2020-10-29, rootId=0, userName=fzwish20004, userId=fe1712732896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dae520254669, moduleTitle=全球第三款RNAi疗法lumasiran即将获批，治疗罕见肝病——1型原发性高草酸尿症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dae520254669)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536870, encodeId=7d1215368e016, content=<a href='/topic/show?id=7cad1554076' target=_blank style='color:#2F92EE;'>#RNAi疗法Lumasiran#</a>, objectTitle=RNAi疗法lumasiran：获得英国MHRA支持治疗1型原发性高草酸尿症, objectType=article, longId=197645, objectId=e51219e64512, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e51219e64512, replyNumber=0, likeNumber=29, createdTime=2020-07-18, rootId=0, userName=fzwish20004, userId=fe1712732896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e51219e64512, moduleTitle=RNAi疗法lumasiran：获得英国MHRA支持治疗1型原发性高草酸尿症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e51219e64512)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536869, encodeId=c16815368697b, content=<a href='/topic/show?id=7cad1554076' target=_blank style='color:#2F92EE;'>#RNAi疗法Lumasiran#</a>, objectTitle=ERA-EDTA 2020：重磅！RNAi疗法Lumasiran治疗高草酸尿症，6个月患者恢复到正常水平, objectType=article, longId=195829, objectId=217019582920, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=217019582920, replyNumber=0, likeNumber=31, createdTime=2020-06-15, rootId=0, userName=fzwish20004, userId=fe1712732896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=217019582920, moduleTitle=ERA-EDTA 2020：重磅！RNAi疗法Lumasiran治疗高草酸尿症，6个月患者恢复到正常水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=217019582920)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1536868, encodeId=ac68153686879, content=<a href='/topic/show?id=7cad1554076' target=_blank style='color:#2F92EE;'>#RNAi疗法Lumasiran#</a>, objectTitle=FDA为Alnylam的RNAi疗法Lumasiran授予优先审查，用于治疗1型原发性高草酸尿症, objectType=article, longId=194823, objectId=beb619482390, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=beb619482390, replyNumber=0, likeNumber=30, createdTime=2020-05-29, rootId=0, userName=fzwish20004, userId=fe1712732896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=beb619482390, moduleTitle=FDA为Alnylam的RNAi疗法Lumasiran授予优先审查，用于治疗1型原发性高草酸尿症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=beb619482390)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

RNAi疗法Lumasiran

2020-05-29

fzwish20004 (审核中...)

前往app查看评论内容

#RNAi疗法Lumasiran#

RNAi疗法lumasiran获得欧盟批准治疗1型原发性高草酸尿症

2020-11-22

fzwish20004 (审核中...)

前往app查看评论内容

#RNAi疗法Lumasiran#

全球第三款RNAi疗法lumasiran即将获批，治疗罕见肝病——1型原发性高草酸尿症

2020-10-29

fzwish20004 (审核中...)

前往app查看评论内容

#RNAi疗法Lumasiran#

RNAi疗法lumasiran：获得英国MHRA支持治疗1型原发性高草酸尿症

2020-07-18

fzwish20004 (审核中...)

前往app查看评论内容

#RNAi疗法Lumasiran#

ERA-EDTA 2020：重磅！RNAi疗法Lumasiran治疗高草酸尿症，6个月患者恢复到正常水平

2020-06-15

fzwish20004 (审核中...)

前往app查看评论内容

#RNAi疗法Lumasiran#

FDA为Alnylam的RNAi疗法Lumasiran授予优先审查，用于治疗1型原发性高草酸尿症

2020-05-29

科室
- - 订阅+
  - 更多科室
工具
服务